Cancer & Metabolism

Papers
(The H4-Index of Cancer & Metabolism is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The diversity and breadth of cancer cell fatty acid metabolism121
DHODH and cancer: promising prospects to be explored80
Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI72
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma49
Pyruvate carboxylase and cancer progression48
Mitochondrial metabolism as a target for acute myeloid leukemia treatment40
Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines34
Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer30
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice28
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism27
Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement25
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer25
Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth24
ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism21
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover21
The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer21
Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells21
MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation21
RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination21
Mass spectrometry imaging of L-[ring-13C6]-labeled phenylalanine and tyrosine kinetics in non-small cell lung carcinoma20
Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer20
0.023190975189209